GlaxoSmithKline plc - ROE
GSK.SW
Price:
$19.976
Market Cap:
$70.12B
Operating globally, GlaxoSmithKline plc (GSK) and its affiliates focus on the research, development, production, and sale of prescription drugs, immunizations, non-prescription medications, and consumer health items across the United Kingdom, the United States, and numerous other international markets. Its operations are structured into four key divisions: Pharmaceuticals, Pharmaceutical Research & Development, Vaccines, and Consumer Healthcare. GSK provides a broad portfolio of pharmaceutical therapies addressing various medical conditions, including respiratory ailments, HIV, immune-inflammatory disorders, cancer, viral infections, central nervous system conditions, cardiovascular and urog...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2007-12-21
Stock Exchange
SIX
Ticker
GSK.SW
PE Ratio
[18.76]
ROE
[28.35%]
Current Ratio
[0.82]
Dividend Yield
[3.89%]
Enterprise Value
[85.26B]
Dividend History
The ROE as of October 2026 (TTM) for GlaxoSmithKline plc (GSK.SW) is 28.35%
According to GlaxoSmithKline plc’s latest financial reports and current stock price. The company's current ROE is 28.35%. This represents a change of 297.27% compared to the average of 7.14% of the last 4 quarters.
GlaxoSmithKline plc (GSK.SW) Historical ROE (quarterly & annually)
How has GSK.SW ROE performed in the past?
The mean historical ROE of GlaxoSmithKline plc over the last ten years is -173.49%. The current 28.35% ROE has changed -116.34% with respect to the historical average. Over the past ten years (40 quarters), GSK.SW's ROE was at its highest in in the December 2017 quarter at 802.94%. The ROE was at its lowest in in the March 2018 quarter at -795.65%.
Average
-173.49%
Median
38.17%
Minimum
-2252.94%
Maximum
141.12%
GlaxoSmithKline plc (GSK.SW) ROE by Quarter and Year
Discovering the peaks and valleys of GlaxoSmithKline plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 384.51%
Maximum Annual ROE = 141.12%
Minimum Annual Increase = -2876.65%
Minimum Annual ROE = -2252.94%
| Year | ROE | Change |
|---|---|---|
| 2025 | 34.90% | 85.30% |
| 2024 | 18.84% | -48.99% |
| 2023 | 36.92% | -73.84% |
| 2022 | 141.12% | 384.51% |
| 2021 | 29.13% | -26.10% |
| 2020 | 39.41% | -3.23% |
| 2019 | 40.73% | -57.50% |
| 2018 | 95.82% | -104.25% |
| 2017 | -2252.94% | -2876.65% |
| 2016 | 81.14% | -50.73% |
GlaxoSmithKline plc (GSK.SW) Average ROE
How has GSK.SW ROE performed in the past?
The current ROE of GlaxoSmithKline plc (GSK.SW) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
30.22%
5-year avg
52.18%
10-year avg
-173.49%
GlaxoSmithKline plc (GSK.SW) ROE vs. Peers
How is GSK.SW’s ROE compared to its peers?
GlaxoSmithKline plc’s ROE is less than EssilorLuxottica S.A. (6.39%), less than Becton, Dickinson and Company (3.79%), less than Fresenius Medical Care AG & Co. KGaA (7.21%), less than Fresenius SE & Co. KGaA (7.89%), greater than Baxter International Inc. (-16.60%), greater than DocMorris AG (-32.84%), greater than MorphoSys AG (-183.80%), greater than ObsEva S.A. (-146.39%), greater than IGEA Pharma N.V. (-320.03%), less than Spexis AG (0%),
| Company | ROE | Market cap |
|---|---|---|
| 6.39% | $88.06B | |
| 3.79% | $72.55B | |
| 7.21% | $8.78B | |
| 7.89% | $12.15B | |
| -16.60% | $42.62B | |
| -32.84% | $404.49M | |
| -183.80% | $2.39B | |
| -146.39% | $140.61K | |
| -320.03% | $505.55K | |
| 0% | $3.86M |
Build a custom stock screener for GlaxoSmithKline plc (GSK.SW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GlaxoSmithKline plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
GlaxoSmithKline plc (GSK.SW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like GlaxoSmithKline plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is GlaxoSmithKline plc's ROE?
How is the ROE calculated for GlaxoSmithKline plc (GSK.SW)?
What is the highest ROE for GlaxoSmithKline plc (GSK.SW)?
What is the 3-year average ROE for GlaxoSmithKline plc (GSK.SW)?
What is the 5-year average ROE for GlaxoSmithKline plc (GSK.SW)?
How does the current ROE for GlaxoSmithKline plc (GSK.SW) compare to its historical average?